Journal of Clinical Pathology and Forensic Medicine
Subscribe to JCPFM
Full Name*
Email Address*

Article Number - 9A315AF53933


Vol.6(3), pp. 11-13 , July 2015
DOI: 10.5897/JCPFM2015.0063
ISSN: 2141-2405



Full Length Research Paper

Prevalent latent adenocarcinoma of the prostate in forensic autopsies



Wei Tian
  • Wei Tian
  • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan. 2International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China.
  • Google Scholar
Motoki Osawa*
  • Motoki Osawa*
  • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Google Scholar







 Received: 20 April 2015  Accepted: 05 June 2015  Published: 31 July 2015

Copyright © 2015 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


In the aging society, elder people commonly suffer cancer, which is associated with increased rates of fractures due to osteoporosis from cancer. In the present study, the prevalence of prostatic cancer, so-called “latent adenocarcinoma”, is investigated among forensic autopsy cases. Retrospective histo-pathology was performed on 114 subjects (61.8 ± 13.3 years old). Forth-four specimens (38.6%) harbored carcinomas with Gleason combined scores ranging from 3 to 9. The detection rate increased in accordance with age, in which the highest rate (8/13, 61.5%) was evident in the group of ≥ 80 years of age. However, no significant associations were apparent to age (P = 0.13) or body mass index (P = 0.36). Majority (34, 77.2%) displayed solitary lesions that were located mainly in the peripheral zone. Advanced capsular invasion was evident in five cases. The prostate that is not familiar to forensic pathologists should be examined in extrinsic fractures of the elderly because cancer might affect injury severity.

 

Key words: Forensic pathology, prostate, gleason score, histopathology, elderly.

Andrews GS (1949). Latent carcinoma of the prostate. J. Clin. Path. 2(3):197-208.
Crossref
 
Brawn PN, Kuhl D, Speights VO, Johnson CF, Lind M (1995). The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma. Arch. Pathol. Lab. Med. 119(8):731-733.
Pubmed
 
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977). Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer. 20(5):680-688.
Crossref
 
Drake MT (2013). Osteoporosis and cancer. Curr. Osteoporos. Rep. 11(3):163-170.
Crossref
 
Gleason DF (1992). Histologic grading of prostate cancer: a perspective. Hum. Pathol. 23:273-279.
Crossref
 
Hsing AW, Tsao L, Devesa SS (2000). International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer. 85(1):60-67.
Crossref
 
Kido M, Hitosugi M, Ishii K, Kamimura S, Joh K (2015). Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study. Prostate. 75(9):917-922.
Crossref
 
Leal J, Hamdy F, Wolstenholme J (2014). Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies. Int. J. Urol. 21(8):786-792.
Crossref
 
Levine B, Titus JM, Moore K, Fowler D (2004). Use of prostate specific antigen in the identification of semen in postmortem cases. Am. J. Forensic Med. Pathol. 25(4):288-290.
Crossref
 
Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD (1995). Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol. Res. Pract. 191(9):838-841.
Crossref
 
Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA. Cancer J. Clin. 64:9-29.
Crossref
 
Takahashi S, Shirai T, Hasegawa R, Imaida K, Ito N (1992). Latent prostatic carcinomas found at autopsy in men over 90 years old. Jpn. J. Clin. Oncol. 22(2):117-121.
Pubmed
 
Tian W, Osawa M, Horiuchi H, Tomita Y (2004). Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 95(6):491-495.
Crossref
 
Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P (1982). Geographic pathology of latent prostatic carcinoma. Int. J. Cancer. 29(6):611-616.
Crossref
 
Zare-Mirzaie A, Balvayeh P, Imamhadi MA, Lotfi M (2012). The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience. Med. J. Islam Repub. Iran. 26(2):73-77.
Pubmed
 
Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Shi GH (2009). Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: Data from China and other Asian countries. Asian J. Androl. 11(1):104-108.
Crossref

 


APA Tian, W., & Osawa*, M. (2015). Prevalent latent adenocarcinoma of the prostate in forensic autopsies. Journal of Clinical Pathology and Forensic Medicine, 6(3), 11-13.
Chicago Wei Tian, and Motoki Osawa. "Prevalent latent adenocarcinoma of the prostate in forensic autopsies." Journal of Clinical Pathology and Forensic Medicine 6, no. 3 (2015): 11-13.
MLA Wei Tian, and Motoki Osawa. "Prevalent latent adenocarcinoma of the prostate in forensic autopsies." Journal of Clinical Pathology and Forensic Medicine 6.3 (2015): 11-13.
   
DOI 10.5897/JCPFM2015.0063
URL http://academicjournals.org/journal/JCPFM/article-abstract/9A315AF53933

Subscription Form